Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Kiniksa Pharmaceuticals International (KNSA) Receivables - Other (2022)

Kiniksa Pharmaceuticals International's Receivables - Other history spans 1 years, with the latest figure at $7.7 million for Q4 2022.

  • For Q4 2022, Receivables - Other changed N/A year-over-year to $7.7 million; the TTM value through Dec 2022 reached $7.7 million, changed N/A, while the annual FY2022 figure was $7.7 million, N/A changed from the prior year.
  • Receivables - Other reached $7.7 million in Q4 2022 per KNSA's latest filing.
  • In the past five years, Receivables - Other ranged from a high of $7.7 million in Q4 2022 to a low of $7.7 million in Q4 2022.